BlackRock Unconstrained Equity Fund Institutional Shares (MAEGX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
14.55
0.00 (0.00%)
May 15, 2025, 8:51 AM EDT
3.49% (1Y)
Fund Assets | 1.29B |
Expense Ratio | n/a |
Min. Investment | $2,000,000 |
Turnover | n/a |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | n/a |
Previous Close | 14.55 |
YTD Return | 4.08% |
1-Year Return | 3.49% |
5-Year Return | 100.52% |
52-Week Low | 11.69 |
52-Week High | 14.82 |
Beta (5Y) | 0.95 |
Holdings | 31 |
Inception Date | Nov 4, 2005 |
About MAEGX
The fund seeks to achieve its investment objective through a fully managed investment policy utilizing global equity securities. For purposes of the fund’s investment policies, equity securities include common stock, preferred stock, convertible securities, warrants, depositary receipts, and securities and other instruments whose price is linked to the value of common stock. It will, under normal circumstances, invest at least 80% of its net assets inequity and equity-related securities. The fund is non-diversified.
Fund Family BlackRock Funds Inst
Category World Large-Stock Growth
Performance Rating Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol MAEGX
Index MSCI World NR USD
Performance
MAEGX had a total return of 3.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.03%.
Top 10 Holdings
59.29% of assetsName | Symbol | Weight |
---|---|---|
Microsoft Corporation | MSFT | 9.12% |
ASML Holding N.V. | ASML | 7.38% |
Meta Platforms, Inc. | META | 6.35% |
Novo Nordisk A/S | NOVO.B | 6.07% |
S&P Global Inc. | SPGI | 5.85% |
Alphabet Inc. | GOOG | 4.98% |
Visa Inc. | V | 4.98% |
Mastercard Incorporated | MA | 4.94% |
Thermo Fisher Scientific Inc. | TMO | 4.89% |
Masimo Corporation | MASI | 4.72% |